Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03915405
Title KHK2455 (IDO Inhibitor) Plus Avelumab in Adult Subjects With Advanced Bladder Cancer
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kyowa Kirin Pharmaceutical Development, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Kyowa Research Site USA001 Saint Petersburg Florida 33709 United States Details
Kyowa Research Site USA005 Iowa City Iowa 52242 United States Details
Kyowa Research Site USA006 Santa Fe New Mexico 87505 United States Details
Kyowa Research Site USA 009 Houston Texas 77030 United States Details
Kyowa Research Site USA007 Milwaukee Wisconsin 53226 United States Details
Kyowa Research Site ESP002 Barcelona 08003 Spain Details
Kyowa Research Site ESP003 Barcelona 08035 Spain Details
Kyowa Research Site ESP004 Madrid 28040 Spain Details
Kyowa Research Site ESP001 Madrid 28050 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field